Skip to main content

Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  203.56
-1.71 (-0.83%)
AAPL  271.23
+5.05 (1.90%)
AMD  211.23
+14.63 (7.44%)
BAC  50.12
-0.95 (-1.87%)
GOOG  307.93
-3.76 (-1.21%)
META  632.88
-4.37 (-0.69%)
MSFT  383.99
-0.48 (-0.12%)
NVDA  188.10
-3.45 (-1.80%)
ORCL  140.84
-0.47 (-0.33%)
TSLA  401.07
+1.24 (0.31%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.